Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis

Joachim Gerber1, Miriam Lotz, Sandra Ebert

  • 1Department of Neurology, Georg-August-University, Gottingen, Germany.

Insights

Melatonin significantly reduced neuronal injury in bacterial meningitis models. This antioxidant may be a valuable adjunctive therapy for human meningitis, improving outcomes by protecting brain cells.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Infectious Diseases

Background:

  • Bacterial meningitis causes neuronal injury through direct toxicity, inflammation, and oxidative stress.
  • Melatonin, an antioxidant, has been explored for neuroprotective effects.

Purpose of the Study:

  • To investigate the efficacy of melatonin as an adjunctive therapy against neuronal injury in experimental bacterial meningitis.

Main Methods:

  • In vitro studies using organotypic hippocampal cultures and human SH-SY5Y cells.
  • In vivo study in rabbits infected with Streptococcus pneumoniae, treated with melatonin and ceftriaxone.

Main Results:

  • Melatonin reduced cellular damage in vitro (P<.001, P<.01).
  • In vivo, melatonin decreased apoptotic dentate granule cells (P=.002) and cerebrospinal fluid nitrite (P=.003), while increasing superoxide dismutase activity (P=.04).

Conclusions:

  • Melatonin demonstrates neuroprotective effects in experimental bacterial meningitis.
  • Melatonin shows potential as an adjunctive therapy to reduce neuronal injury in human meningitis.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...